MedPath

Carboprost Tromethamine

Approved
Approval ID

6484c309-2041-4c25-a233-9d1fb6da583c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 1, 2023

Manufacturers
FDA

STELIS BIOPHARMA LIMITED

DUNS: 867530307

FDA

ONESOURCE SPECIALTY PHARMA LIMITED

DUNS: 867530307

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Carboprost Tromethamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code83270-002
Application NumberANDA216897
Product Classification
M
Marketing Category
C73584
G
Generic Name
Carboprost Tromethamine
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateAugust 1, 2023
FDA Product Classification

INGREDIENTS (4)

BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
TROMETHAMINEInactive
Code: 023C2WHX2V
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
CARBOPROST TROMETHAMINEActive
Quantity: 250 ug in 1 mL
Code: U4526F86FJ
Classification: ACTIM

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 9/23/2024

PRINCIPAL DISPLAY PANEL

NDC 83270-002-01

Carboprost Tromethamine Injection, USP 250 mcg/mL

For Intramuscular use only

Rx Only

1 mL

image-vial

NDC83270-002-02

Contains 10 of NDC 83270-002-01

Carboprost Tromethamine Injection, USP 250 mcg/mL

For Intramuscular use only

10 x 1 mL Single-Dose Vials

Rx Only Steriscience

image-carton

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 9/23/2024

HOW SUPPLIED

Carboprost tromethamine injection, USP Sterile Solution is available in the following packages:

1 mL single-dose vial NDC 83270-002-01

10 x 1 mL single-dose vials NDC 83270-002-02

Each mL of carboprost tromethamine injection contains carboprost tromethamine equivalent to 250 mcg of carboprost.

Carboprost tromethamine injection must be refrigerated at 2° to 8° C (36° to 46° F).

Discard unused portion.

Rx only

Manufactured For:

Steriscience Specialities Pte. Limited

Revised: September 2024

To report SUSPECTED ADVERSE REACTIONS, contact Steriscience at 1-888-278-1784 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

DESCRIPTION SECTION

LOINC: 34089-3Updated: 9/23/2024

DESCRIPTION

Carboprost tromethamine injection, USP Sterile Solution, an oxytocic, contains the tromethamine salt of the (15S)-15 methyl analogue of naturally occurring prostaglandin F2α in a solution suitable for intramuscular injection. Carboprost tromethamine is the established name for the active ingredient in Carboprost tromethamine injection, USP. Four other chemical names are:
1. (15S)-15-methyl prostaglandin F2α tromethamine salt
2. 7-(3α,5α-dihydroxy-2ß-[(3S)-3-hydroxy-3-methyl- trans-1-octenyl]-1α-cyclopentyl]-cis-5-heptenoic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol
3. (15S)-9α,11α,15-trihydroxy-15-methylprosta-cis-5, trans-13-dienoic acid tromethamine salt
4. (15S)-15-methyl PGF2α-THAM
The structural formula is represented below:

![chemical-structure](/dailymed/image.cfm?name=chemical- structure.jpg&id=876379)

The molecular formula is C25H47O8N. The molecular weight of carboprost tromethamine is 489.64. It is a white to slightly off-white crystalline powder. It generally melts between 95° and 105° C, depending on the rate of heating.

Carboprost tromethamine dissolves readily in water at room temperature at a concentration greater than 75 mg/mL.
Each mL of carboprost tromethamine injection, USP Sterile Solution contains carboprost tromethamine equivalent to 250 mcg of carboprost, 83 mcg tromethamine, 9 mg sodium chloride, and 9.45 mg benzyl alcohol added as preservative. When necessary, pH is adjusted with sodium hydroxide and/or hydrochloric acid. The solution is sterile.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.